Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diflunisal in Familial Amyloid Polyneuropathy
NCT00294671Phase 3Completed
- Sponsor
- Boston University
- Start
- Feb 2006
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial in familial amyloid polyneuropathy (FAP) comparing Diflunisal with Placebo (2 arms). Primary endpoint: Neurologic Impairment Score + 7 at 2 years. Started Feb 2006; status: completed.
02
Drugs
diflunisal
03
Conditions
familial amyloid polyneuropathy (FAP)
Beyond the preview
Go deeper on NCT00294671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00294671.